Cellenkos is an early stage clinical biotechnology company that focuses on umbilical cord blood derived T-regulatory cellular therapies for treating autoimmune diseases and inflammatory disorders.
View Top Employees from Cellenkos, Inc.Website | http://cellenkosinc.com |
Revenue | $6 million |
Employees | 17 (16 on RocketReach) |
Founded | 2016 |
Address | 5416 Chaucer Dr, Houston, Texas 77005, US |
Phone | (800) 217-8247 |
Technologies |
JavaScript,
HTML,
Google Analytics
+4 more
(view full list)
|
Industry | Biotechnology, Medical Testing & Clinical Laboratories, Pharmaceuticals, Healthcare |
SIC | SIC Code 283 Companies, SIC Code 873 Companies, SIC Code 87 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 325414 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Cellenkos, Inc. employee's phone or email?
The Cellenkos, Inc. annual revenue was $6 million in 2024.
Simrit Parmar is the Founder of Cellenkos, Inc..
16 people are employed at Cellenkos, Inc..
Cellenkos, Inc. is based in Houston, Texas.
The NAICS codes for Cellenkos, Inc. are [54, 541, 325, 32541, 325414, 3254, 32].
The SIC codes for Cellenkos, Inc. are [283, 873, 87, 28].